| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-10 |
| mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-08 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-07 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
1e-06 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
7e-06 |